Rhythm

Implicity Releases SMART on FHIR App

New app improves cardiac remote monitoring workflows by providing clinicians access to Implicity alerts and reports directly within Epic’s electronic medical records systems.  CAMBRIDGE, Mass., March 2, 2023 /PRNewswire/ — Implicity®, a leader in remote patient monitoring (RPM) and cardiac data management solutions, released a new SMART on FHIR application to improve interoperability and […]

Lohman Technologies’ latest HomECG+ device promotes health equity with ease of use and embedded cellular technology

The latest version of the HomECG+ helps close the health equity gap by providing access to care for all patient types, including rural health, underserved populations, geographic disparities, and low-income populations. MILWAUKEE, March 2, 2023 /PRNewswire/ — Lohman Technologies recently announced the release of their 2.0, next-generation, HomECG+ product. The FDA-cleared, clinical-grade […]

Vivalink’s Biometrics Data Platform Supports UCSF Clinical Trial for Hypertrophic Cardiomyopathy (HCM)

The six-month EXCITE-HCM study of 70 patients will study the effects of exercise on electrical activity and blood flow using Vivalink’s medical wearable ECG sensor and cloud data services. CAMPBELL, Calif., March 1, 2023 /PRNewswire/ — UC San Francisco (UCSF) is conducting a six-month clinical trial on hypertrophic cardiomyopathy (HCM) using Vivalink‘s Biometrics Data Platform. […]

New Heart Health Education Components Arrive on OMRON Connect Mobile App

OMRON Healthcare celebrates Heart Health Month with new education components providing tips for AFib identification, quality sleep, healthy recipes, and lifestyle changes that may help reduce heart attack and stroke risk HOFFMAN ESTATES, Ill., Feb. 28, 2023 /PRNewswire/ — Global heart health leader OMRON Healthcare is celebrating Heart Health Month with new […]

ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

Primary Results from RADIANCE II Trial Published in JAMA and Results of Pooled Analysis from Three RADIANCE Studies Published in JAMA Cardiology PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced that primary endpoint results from the RADIANCE […]

Eko Launches SENSORA™ Cardiac Disease Detection Platform

Enterprise-grade digital stethoscope platform brings non-invasive heart disease detection to primary care OAKLAND, Calif., Feb. 23, 2023 /PRNewswire/ — Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease, today announced the launch of the SENSORA™ Cardiac Disease Detection Platform. SENSORA™ currently features AI that objectively identifies structural […]

Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms

EV-ICD defibrillation lead placed outside of heart and veins, preserving vasculature DUBLIN, Feb. 17, 2023 /PRNewswire/ — Medtronic plc (NYSE:MDT) has received CE (Conformité Européenne) Mark for the Aurora EV-ICD™ MRI SureScan™ (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV™ MRI SureScan™ defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden […]

Syntach and Meditrial announce partnership covering clinical development of Cardiac Support System

LUND, Sweden, Feb 9, 2023 /PRNewswire/ – Syntach AB (“Syntach”) is pleased to announce that it has entered into a partnership agreement with Meditrial Europe Ltd (“Meditrial”) to support the clinical and regulatory strategies of Syntach’s innovative minimally invasive cardiac support system. Over 64 million people suffer from heart failure, one of […]

Medtronic LINQ Insertable Cardiac Monitor detects 10 times more atrial fibrillation in ischemic stroke patients at three years compared to standard of care

ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients DUBLIN and DALLAS, Feb. 8, 2023 /PRNewswire/ — Medtronic (NYSE: MDT) today announced late-breaking clinical data from the STROKE AF clinical study, which showed large and small vessel disease stroke patients had a 10-fold increase in AF […]

Bayer Announces First Patients Enrolled in Global Phase III Studies for Investigational Oral FXIa Inhibitor Asundexian

The OCEANIC program will investigate the efficacy and safety of asundexian (BAY2433334) in the prevention of stroke in patients with atrial fibrillation and also patients with a non-cardioembolic ischemic stroke or high-risk transient ischemic attack (TIA)1,2 OCEANIC-AF and OCEANIC-STROKE are expected to enroll more than 27,000 patients in over 40 […]